Announced Fri, 15 May · 19:24 IST

Monitoring Agency Report enclosed

EMKAY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+12.1%1-day move
₹194.50
prior close
₹200.81
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.6+5.3+5.3+9.1+12.1+13.7+13.9+14.7+14.9+14.4+44.2+49.2+25.3
Up moveDown movePending
AI summary

CARE Ratings Limited has submitted the Monitoring Agency Report for Emkay Global Financial Services for the quarter ended March 31, 2026. The report covers the Rs. 227.52 crore preferential issue of convertible warrants conducted in October 2025. Of the total issue size, Rs. 66.88 crore has been received so far (₹61.88 crore in Q3 and ₹4.99 crore in Q4 representing the remaining 75% of warrant consideration). All received funds have been fully utilized for working capital requirements as stated in the offer document. A fixed deposit of ₹4.99 crore has been placed with the clearing corporation. There are no deviations from the stated objects of the issue, and no material concerns noted. The remaining ₹160.64 crore is yet to be called.

Likely market impact

This is a routine regulatory filing confirming proper utilization of funds raised through the preferential warrant issue. No deviations or adverse findings from the monitoring agency suggest the company is on track with its stated objectives. The nil deviation declaration is positive for investor confidence.